Drug Therapy for Asthma and Bronchoconstriction Ch 31

Question 1

Airway hyperresponsiveness

Answer 1

exaggerated bronchoconstrictive response to stimuli

Question 2

Bronchospasm (also called bronchoconstriction)

Answer 2

constriction of the air passages of the lung (as in asthma) by spasmodic contraction of the bronchial muscles

Question 3

Leukotrienes

Answer 3

strong chemical mediators of bronchoconstriction and inflammation, the major pathologic features of asthma

Question 4

Maintenance inhalant medications

Answer 4

long-term control beta2-agonists used to achieve and maintain prophylactic control of persistent asthma

Question 5

Mast cells

Answer 5

cells releasing substances that produce bronchoconstriction and inflammation in response to causative stimuli

Question 6

Rescue inhalant medications

Answer 6

quick-relief, short-acting beta2-agonists used during periods of acute symptoms and exacerbations

Question 7

Status asthmaticus

Answer 7

acute, severe asthma

Question 8

Triggers

Answer 8

factors that initiate asthma symptoms

Question 9

Work-exacerbated asthma

Answer 9

adverse respiratory outcome resulting from work-related conditions